Testing Digital Cancer Rehabilitation Across Five Baltic Countries
A new feasibility study is evaluating how digitally supported physical exercise programs can be equitably implemented during and after cancer treatment.
Key takeaways
- The AMBeR eRehab study is evaluating the feasibility of digitally supported physical cancer rehabilitation across five South Baltic countries.
- The study aims to enroll a total of 300 adult cancer patients, split between those undergoing systemic treatment and those who have completed or are on long-term treatment.
- Investigators are using the RE-AIM framework and Group Concept Mapping to study participation barriers for patients and delivery barriers for healthcare providers.
- Enrollment for the multicenter, prospective feasibility trials began in September 2024 and is projected to finish by December 2026.
Research in exercise oncology has consistently demonstrated that physical activity is beneficial when integrated into all phases of cancer care. However, less is known about how to implement these exercise programs across different patient populations and healthcare settings. A newly published clinical trial protocol is addressing this implementation gap by investigating a digitally supported physical rehabilitation program for cancer patients in northern Europe.
The AMBeR eRehab study, which is part of the larger gAMBeRh project (Advanced Modeling of Baltic E-cancer caRe), is an international, multicenter, prospective study. It uses a hybrid implementation-effectiveness design to evaluate the feasibility of delivering digital physical rehabilitation to adult cancer patients during and after systemic treatment.
By focusing on feasibility, reach, and equitable delivery, the investigators hope to generate insights that prevent digital health solutions from inadvertently exacerbating existing healthcare disparities. This research is designed to help ensure that technological innovations do not remain inaccessible to cancer patients who have fewer resources.
What Happened
Researchers have initiated the AMBeR eRehab study across five South Baltic countries to test the feasibility of a digitally supported physical rehabilitation protocol. The study is structured around two single-arm feasibility trials. The trials are open to adult cancer patients aged 18 and older from all tumor groups.
Each participating site aims to enroll two distinct patient cohorts: 30 patients who are actively undergoing systemic cancer treatment, and 30 patients who have completed systemic treatment or are receiving long-term or life-prolonging therapy. Across all participating sites, the investigators aim to enroll a total of 300 patients. Enrollment for the study began in September 2024 and is expected to be completed by December 2026.
What The Evidence Shows
Because the publication in Advances in clinical and experimental medicine describes a study protocol rather than completed trial results, clinical efficacy data are not yet available. To evaluate the trial, the researchers are structuring their data collection and reporting around the RE-AIM framework, which stands for Reach, Effectiveness, Adoption, Implementation, and Maintenance.
Additionally, the study is utilizing Group Concept Mapping to evaluate specific determinants of the intervention. This mapping will look at factors influencing participation among patients, as well as factors affecting how healthcare professionals deliver the physical rehabilitation program.
What We Don't Know Yet
As a protocol and feasibility study, this work does not yet provide clinical outcome data or establish the long-term effectiveness of the digital intervention. The single-arm design of the feasibility trials means there is no control group for direct comparison. Furthermore, the study is restricted to five countries in the South Baltic region, and the primary source does not report specific details about the digital platform's features, the exact types of exercise prescribed, or the primary clinical endpoints.
What Comes Next
Patient enrollment is scheduled to continue through December 2026. The published source does not report specific plans for subsequent clinical trials, regulatory submissions, or platform expansions after the feasibility phase is complete.
What This Means
The study seeks to build an implementation framework for delivering digital exercise programs in cancer care without reinforcing existing social or economic inequalities. If successful, the feasibility data could guide the design of future, larger trials and help healthcare systems integrate virtual physical rehabilitation into standard oncology care.
Original Source
PubMed (NCBI E-utilities): https://pubmed.ncbi.nlm.nih.gov/42709020/
Questions readers ask
- What is the main goal of the AMBeR eRehab study?
- The study aims to evaluate the feasibility and equitable implementation of digitally supported physical rehabilitation during and after systemic cancer treatment. It seeks to generate knowledge on how to implement exercise oncology programs across different patient populations without exacerbating disparities.
- Who is eligible to participate in this rehabilitation trial?
- Adult cancer patients aged 18 and older from any tumor group are eligible. The trials are enrolling both patients currently undergoing systemic treatment and those who have finished treatment or are receiving long-term, life-prolonging care.
- Which countries are participating in the research?
- The study is being conducted across five countries in the South Baltic region as part of the broader gAMBeRh project (Advanced Modeling of Baltic E-cancer caRe).
- How long will the trial enrollment last?
- Enrollment for the AMBeR eRehab feasibility study began in September 2024 and is expected to be completed in December 2026.
What this means
The study seeks to build an implementation framework for delivering digital exercise programs in cancer care without reinforcing existing social or economic inequalities. If successful, the feasibility data could guide the design of future, larger trials and help healthcare systems integrate virtual physical rehabilitation into standard oncology care.
Limitations and uncertainties
- As a protocol and feasibility study, this work does not yet provide clinical outcome data or establish the long-term effectiveness of the digital intervention. The single-arm design of the feasibility trials means there is no control group for direct comparison. Furthermore, the study is restricted to five countries in the South Baltic region, and the primary source does not report specific details about the digital platform's features, the exact types of exercise prescribed, or the primary clinical endpoints.
